Breaking News
Investing Pro 0
Cyber Monday SALE: Up to 54% OFF InvestingPro+ CLAIM OFFER

CVS: Cheap Dividend Stock Can Generate High Future Returns

By Bob CiuraStock MarketsOct 15, 2020 09:05PM ET
www.investing.com/analysis/cvs-cheap-dividend-stock-can-generate-high-future-returns-200541241
CVS: Cheap Dividend Stock Can Generate High Future Returns
By Bob Ciura   |  Oct 15, 2020 09:05PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
US500
-0.03%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
SPY
-0.02%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AET
0.00%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
CVS
+1.20%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Value investors seek to buy stocks trading below their intrinsic value, a term popularized by legendary value investor Warren Buffett. At its core, value investing is trying to buy a dollar for 50 cents. Value investors are always on the hunt for cheap stocks that are trading for less than they are worth.

On the other hand, income investors typically aim to buy stocks with high dividend yields above the S&P 500 average. With interest rates at zero and stock prices near record highs, income investors might want to focus on stocks with dividend yields above 3%.

The two strategies—value and income investing—can also be combined. We believe CVS (NYSE:CVS) (CVS) is a cheap dividend stock. CVS has a 3.4% dividend yield, and the stock is trading at a very low valuation which makes it an attractive stock for value and income investors.

Business Overview

CVS Health Corporation is an integrated health-care services provider. The company operates more than 9,900 retail locations and 1,100 medical clinics. CVS also services more than 102 million plan members after the $78-billion acquisition of Aetna (NYSE:AET) in 2018. CVS generates annual revenues of about $265 billion.

CVS stock has performed poorly this year, down 20% year-to-date. For comparison, the S&P 500 Index has increased 7% year-to-date. The deep under-performance of CVS implies the company’s financial results have deteriorated, but that is far from the case. CVS has actually performed quite well in 2020, reporting solid growth across its key metrics.

CVS released earnings results for the second quarter on 8/4/2020. Revenue increased 3% to $65.3 billion, while adjusted earnings-per-share increased 40% year-over-year. The COVID-19 pandemic added an estimated $0.70 to $0.80 to adjusted earnings-per-share and $1.8 to $2.1 billion to revenue results during the quarter, due to higher demand for healthcare products. While so many companies across multiple industries are struggling to keep their profits afloat, CVS is reporting impressive growth in revenue and earnings.

Front of store sales declined 4.5%, which was attributed to less customer traffic due to shelter-in-place directives, but was partially offset with higher average basket size. Same store sales improved 2.4% from the previous year, while medical memberships overall increased 3.3% to 23.6 million members. We expect these growth tailwinds to continue in 2021 and beyond.

Growth Prospects

CVS has a strong historical growth profile. In the past decade, the company grew earnings-per-share by approximately 10% per year. Major health-care providers like CVS are set to benefit over the long-term, from the favorable trends taking place in the United States, specifically the aging population. The company will capitalize on this growth opportunity with a multitude of competitive advantages.

CVS’s most compelling competitive advantage is its entrenched position in the pharmaceutical retail industry. The industry is highly regulated, which makes it difficult for new competitors to enter into the industry and gain market share. In addition, the company is one of the largest pharmacies in the United States (along with Walgreens), which allows it to capture economies of scale and pressure its suppliers into delivering better prices.

Consumers are unlikely to cut spending on prescriptions, health insurance, and other health-care products and services, even during difficult economic times. We believe this makes CVS resistant to recessions. From 2008 through 2010, during a deep economic downturn known as the Great Recession, CVS actually increased its diluted earnings-per-share by 10% over this period. The company has also continued to perform well in 2020, despite the U.S. economy officially entering a recession in February.

2020 is expected to be another highly profitable year for CVS. The company now expects adjusted earnings-per-share of $7.14 to $7.27 for the full year, up from $7.04 to $7.17 previously. Therefore, the steep decline in the share price over the course of 2020 means shares are now deeply undervalued.

Dividends, Valuation And Expected Returns

Based on expected fiscal 2020 adjusted EPS of $7.21, CVS stock trades at a price-to-earnings ratio (P/E) of just 8.2. This is a low multiple, particularly for an industry-leading company with a high level of profitability and a positive future growth outlook. The stock has held an average price-to-earnings ratio of 14.6 over the past decade. Our fair value estimate is a P/E ratio of 11.0, which we view as a reasonable fair value P/E multiple.

Still, this means the stock could be significantly undervalued today. This is important, as an expansion of the price-to-earnings ratio could add 6.1% to the annualized returns of the stock over the next five years. We expect this expansion to combine with 5% expected annualized EPS growth and the 3.4% dividend yield, leading to total expected returns above 14% per year for CVS stock, over the next five years.

Dividends are expected to grow in the long term, but in the short term CVS management has prioritized debt repayment. This is a prudent move by management, as the company absorbed a large amount of debt to finance the Aetna acquisition. Therefore, investors should not expect the dividend to be increased until 2022. Even so, CVS has appeal for income investors, as the 3.4% dividend yield is well above the ~1.8% average yield of the broader S&P 500 Index. And, importantly the dividend payout is highly secure, as CVS has a projected dividend payout ratio of 28% for 2020.

Final Thoughts

Even though stocks have widely recovered their coronavirus-induced losses, evident by the recovery in the S&P 500 Index, investors can still find cheap stocks. There are still multiple high-quality companies with solid dividend yields, that are trading below their intrinsic value. One example is CVS, a leader in pharmaceutical retail that is quickly becoming a diversified healthcare conglomerate.

CVS has a positive long-term growth outlook, but the current valuation of the stock does not adequately price in this growth potential. Investors don’t have pick value or growth with CVS; they get both. We view CVS as a cheap stock, and the 3.4% dividend yield makes it an attractive pick for value and income investors.

CVS: Cheap Dividend Stock Can Generate High Future Returns
 

Related Articles

CVS: Cheap Dividend Stock Can Generate High Future Returns

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email